Arianna Landini
Arianna Landini has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
- Nicola Pirastu
Human Technopole, Milan, Italy
5 shared publications - Sodbo Zh Sharapov
MSU Institute for Artificial Intelligence, Lomonosov Moscow State University, Moscow, Russia
5 shared publications - Craig A. Glastonbury
Human Technopole, Milan, Italy
4 shared publications - Edoardo Giacopuzzi
Fondazione Human Technopole, Via Levi Montalcini 1, 20157 Milano, Italy
4 shared publications - James F. Wilson
University of Edinburgh
4 shared publications - Lucija Klaric
MRC Human Genetics Unit, University of Edinburgh, Institute of Genetics and Cancer, Western General Hospital, Edinburgh, UK
4 shared publications
Latest Publications
- Open Access
Circulating immune architecture across age, exposures and disease in ethnically diverse UK cohorts.
Human immune composition reflects genetic background and cumulative life-course exposures, yet how these influences shape immune architecture across populations and disease remains poorly understood. Here we integrate single-cell transcriptomics, matched clinical haematology and electronic health records from 5,079 individuals of European, British-Pakistani and British-Bangladeshi ancestries to quantify 26 circulating immune cell types and 62 transcriptional states. We map immune compositional variation associated with age, sex, adiposity and smoking, revealing distinct patterns across adulthood and associations between modifiable exposures and advanced immune age. Across common diseases, immune compositional signatures converge on recurrent inflammatory myeloid, adaptive-memory and interferon programmes, whose expression varies with age and population context. Cardiovascular therapies are associated with selective shifts in disease-associated immune states. Immune composition further discriminates common cardiometabolic diseases and resolves patients into endotypes with distinct metabolic and clinical profiles. These findings establish circulating immune architecture as an integrative phenotype linking life-course exposures, population context and disease, providing a framework for precision population immunology.
Open AccessCirculating immune architecture across age, exposures and disease in ethnically diverse UK cohorts.
Human immune composition reflects genetic background and cumulative life-course exposures, yet how these influences shape immune architecture across populations and disease remains poorly understood. Here we integrate single-cell transcriptomics, matched clinical haematology and electronic health records from 5,079 individuals of European, British-Pakistani and British-Bangladeshi ancestries to quantify 26 circulating immune cell types and 62 transcriptional states. We map immune compositional variation associated with age, sex, adiposity and smoking, revealing distinct patterns across adulthood and associations between modifiable exposures and advanced immune age. Across common diseases, immune compositional signatures converge on recurrent inflammatory myeloid, adaptive-memory and interferon programmes, whose expression varies with age and population context. Cardiovascular therapies are associated with selective shifts in disease-associated immune states. Immune composition further discriminates common cardiometabolic diseases and resolves patients into endotypes with distinct metabolic and clinical profiles. These findings establish circulating immune architecture as an integrative phenotype linking life-course exposures, population context and disease, providing a framework for precision population immunology.
- Open Access
Multimodal population-scale cell atlases define archetypes and extremes of human blood
The cellular composition of blood is fundamental to human physiology and is routinely measured to assess health and disease. Circulating immune cells show extensive heterogeneity, but the organising principles and extremes of variation across individuals remain undefined. Here, using single-cell transcriptomics across two biobank cohorts encompassing ~6,000 individuals, we show that human blood occupies recurrent archetypal states defined by coordinated cell composition patterns. We delineate three major archetypes spanning naive lymphoid, myeloid and cytotoxic composition, and two minor archetypes characterised by type I interferon-driven inflammation and expanded premalignant CD5+ B cells. We develop cell2clone to infer lymphocyte clonal expansions, revealing how reactive clonal processes drive the cytotoxic archetype and premalignant clonal expansion establishes the CD5+ B cell archetype, creating outlier states that uncover context-specific effects of germline variants. Clonal haematopoiesis and mosaic chromosomal alterations influence blood states in an archetype-dependent manner. The archetype framework links blood states to common disease risk and clinical blood counts and, through a machine-learning model ArcheTypist, classifies infection and cancer immunotherapy outcomes. This population-scale framework has implications for diagnostics, early disease detection, immunotherapy stratification and mechanistic insights into disease susceptibility and therapy response, providing an organising model for identifying compositional subtypes across human tissues.
Open AccessMultimodal population-scale cell atlases define archetypes and extremes of human blood
The cellular composition of blood is fundamental to human physiology and is routinely measured to assess health and disease. Circulating immune cells show extensive heterogeneity, but the organising principles and extremes of variation across individuals remain undefined. Here, using single-cell transcriptomics across two biobank cohorts encompassing ~6,000 individuals, we show that human blood occupies recurrent archetypal states defined by coordinated cell composition patterns. We delineate three major archetypes spanning naive lymphoid, myeloid and cytotoxic composition, and two minor archetypes characterised by type I interferon-driven inflammation and expanded premalignant CD5+ B cells. We develop cell2clone to infer lymphocyte clonal expansions, revealing how reactive clonal processes drive the cytotoxic archetype and premalignant clonal expansion establishes the CD5+ B cell archetype, creating outlier states that uncover context-specific effects of germline variants. Clonal haematopoiesis and mosaic chromosomal alterations influence blood states in an archetype-dependent manner. The archetype framework links blood states to common disease risk and clinical blood counts and, through a machine-learning model ArcheTypist, classifies infection and cancer immunotherapy outcomes. This population-scale framework has implications for diagnostics, early disease detection, immunotherapy stratification and mechanistic insights into disease susceptibility and therapy response, providing an organising model for identifying compositional subtypes across human tissues.
- Open Access
- 29 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Hundreds of cardiac MRI traits derived using 3D diffusion autoencoders share a common genetic architecture
Biobank-scale imaging provides an unprecedented opportunity to characterise how thousands of organ phenotypes vary in populations. However, deriving specific phenotypes from imaging data requires time-consuming expert annotation, limiting scalability. In this study, we develop a 3D diffusion autoencoder to derive latent phenotypes from temporally resolved cardiac MRI data of 71,017 UK Biobank participants. These phenotypes are reproducible, heritable (h2 = [4—18%]), and significantly associated with cardiometabolic traits. To establish the genetic basis of such traits, we perform a genome-wide association study, identifying 89 significant common variants (P < 2.3 × 10−9) across 42 loci, including seven novel loci. Extensive multi-trait colocalisation analyses (PP.H4 > 0.8) link variants across phenotypic scales, from intermediate cardiac traits to cardiac disease endpoints. In conclusion, this study showcases the use of diffusion autoencoding methods as powerful tools for unsupervised phenotyping, genetic discovery and disease risk prediction using cardiac MRI data.
- 29 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessHundreds of cardiac MRI traits derived using 3D diffusion autoencoders share a common genetic architecture
Biobank-scale imaging provides an unprecedented opportunity to characterise how thousands of organ phenotypes vary in populations. However, deriving specific phenotypes from imaging data requires time-consuming expert annotation, limiting scalability. In this study, we develop a 3D diffusion autoencoder to derive latent phenotypes from temporally resolved cardiac MRI data of 71,017 UK Biobank participants. These phenotypes are reproducible, heritable (h2 = [4—18%]), and significantly associated with cardiometabolic traits. To establish the genetic basis of such traits, we perform a genome-wide association study, identifying 89 significant common variants (P < 2.3 × 10−9) across 42 loci, including seven novel loci. Extensive multi-trait colocalisation analyses (PP.H4 > 0.8) link variants across phenotypic scales, from intermediate cardiac traits to cardiac disease endpoints. In conclusion, this study showcases the use of diffusion autoencoding methods as powerful tools for unsupervised phenotyping, genetic discovery and disease risk prediction using cardiac MRI data.
- Open Access
Hundreds of cardiac MRI traits derived using 3D diffusion autoencoders share a common genetic architecture
Biobank-scale imaging provides an unprecedented opportunity to characterise thousands of organ phenotypes, how they vary in populations and how they relate to disease outcomes. However, deriving specific phenotypes from imaging data, such as Magnetic Resonance Imaging (MRI), requires time-consuming expert annotation, limiting scalability, and does not exploit how information-dense such image acquisitions are. In this study, we developed a 3D diffusion autoencoder to derive latent phenotypes from temporally resolved cardiac MRI data of 71,021 UK Biobank participants. These phenotypes were reproducible, heritable ( h 2 = [4 - 18%]), and significantly associated with cardiometabolic traits and outcomes, including atrial fibrillation ( P = 8.5 × 10 −29 ) and myocardial infarction ( P = 3.7 × 10 −12 ). By using latent space manipulation techniques, we were able to learn, directly interpret and visualise what specific latent phenotypes are capturing in a given MRI. To establish the genetic basis of such traits, we performed a genome-wide association study, identifying 89 significant common variants ( P < 2.3 × 10 −9 ) across 42 loci, including seven novel loci. Extensive multi-trait colocalisation analyses (PP.H 4 > 0.8) linked variants across phenotypic scales, from intermediate cardiac traits to cardiac disease endpoints. For example, rs142556838 that falls in CCDC141 colocalises with a latent imaging phenotype and a diastolic blood pressure locus. Using single-cell RNA-sequencing data we map CCDC141 expression specifically to a population of ventricular cardiomyocytes. Finally, Polygenic Risk Scores (PRS) derived from latent phenotypes demonstrated predictive power for a range of cardiometabolic diseases and enabled us to successfully stratify the individuals into different risk groups. In conclusion, this study showcases the use of diffusion autoencoding methods as powerful tools for unsupervised phenotyping, genetic discovery and disease risk prediction using cardiac MRI data.
Open AccessHundreds of cardiac MRI traits derived using 3D diffusion autoencoders share a common genetic architecture
Biobank-scale imaging provides an unprecedented opportunity to characterise thousands of organ phenotypes, how they vary in populations and how they relate to disease outcomes. However, deriving specific phenotypes from imaging data, such as Magnetic Resonance Imaging (MRI), requires time-consuming expert annotation, limiting scalability, and does not exploit how information-dense such image acquisitions are. In this study, we developed a 3D diffusion autoencoder to derive latent phenotypes from temporally resolved cardiac MRI data of 71,021 UK Biobank participants. These phenotypes were reproducible, heritable ( h 2 = [4 - 18%]), and significantly associated with cardiometabolic traits and outcomes, including atrial fibrillation ( P = 8.5 × 10 −29 ) and myocardial infarction ( P = 3.7 × 10 −12 ). By using latent space manipulation techniques, we were able to learn, directly interpret and visualise what specific latent phenotypes are capturing in a given MRI. To establish the genetic basis of such traits, we performed a genome-wide association study, identifying 89 significant common variants ( P < 2.3 × 10 −9 ) across 42 loci, including seven novel loci. Extensive multi-trait colocalisation analyses (PP.H 4 > 0.8) linked variants across phenotypic scales, from intermediate cardiac traits to cardiac disease endpoints. For example, rs142556838 that falls in CCDC141 colocalises with a latent imaging phenotype and a diastolic blood pressure locus. Using single-cell RNA-sequencing data we map CCDC141 expression specifically to a population of ventricular cardiomyocytes. Finally, Polygenic Risk Scores (PRS) derived from latent phenotypes demonstrated predictive power for a range of cardiometabolic diseases and enabled us to successfully stratify the individuals into different risk groups. In conclusion, this study showcases the use of diffusion autoencoding methods as powerful tools for unsupervised phenotyping, genetic discovery and disease risk prediction using cardiac MRI data.
- Open Access
Integrating Natural and Engineered Genetic Variation to Decode Regulatory Influence on Blood Traits
Understanding the function of genetic variants associated with human traits and diseases remains a significant challenge. Here we combined analyses based on natural genetic variation and genetic engineering to dissect the function of 94 non-coding variants associated with haematological traits. We describe 22 genetic variants impacting haematological variation through gene expression. Further, through in-depth functional analysis, we illustrate how a rare, non-coding variant near the CUX1 transcription factor impacts megakaryopoiesis through modulation of the CUX1 transcriptional cascade. Collectively, our findings enhance the functional interpretation of genetic association studies and advance understanding of how non-coding variants contribute to blood and immune system variation.
Open AccessIntegrating Natural and Engineered Genetic Variation to Decode Regulatory Influence on Blood Traits
Understanding the function of genetic variants associated with human traits and diseases remains a significant challenge. Here we combined analyses based on natural genetic variation and genetic engineering to dissect the function of 94 non-coding variants associated with haematological traits. We describe 22 genetic variants impacting haematological variation through gene expression. Further, through in-depth functional analysis, we illustrate how a rare, non-coding variant near the CUX1 transcription factor impacts megakaryopoiesis through modulation of the CUX1 transcriptional cascade. Collectively, our findings enhance the functional interpretation of genetic association studies and advance understanding of how non-coding variants contribute to blood and immune system variation.
- Open Access
Exome sequencing reveals aggregates of rare variants in glycosyltransferase and other genes influencing immunoglobulin G and transferrin glycosylation
It is often difficult to be certain which genes underlie the effects seen in association studies. However, variants that disrupt the protein, such as predicted loss of function (pLoF) and missense variants, provide a shortcut to identify genes with a clear biological link to the phenotype of interest. Glycosylation is one of the most common post-translationalmodifications of proteins, and an important biomarker of both disease and its progression. Here, we utilised the power of genetic isolates, gene-based aggregation tests and intermediate phenotypes to assess the effect of rare (MAF−8 ) and for IgG glycan traits at 4 genes (p−7 ). Associations in three of these genes ( FUT8, MGAT3 and RFXAP ) are driven by multiple rare variants simultaneously contributing to protein glycosylation. Association at ST6GAL1 , with a 300-fold up-drifted variant in the Orkney Islands, was detectable by a single-point exome-wide association analysis. Glycome-associated aggregate associations are located in genes already known to have a biological link to protein glycosylation ( FUT6, FUT8 for transferrin; FUT8, MGAT3 and ST6GAL1 for IgG) but also in genes which have not been previously reported (e.g. RFXAP for IgG). To assess the potential impact of rare variants associated with glycosylation on other traits, we queried public repositories of gene-based tests, discovering a potential connection between transferrin glycosylation, MSR1 , galectin-3, insulin-like growth factor 1 and diabetes. However, the exact mechanism behind these connections requires further elucidation.
Open AccessExome sequencing reveals aggregates of rare variants in glycosyltransferase and other genes influencing immunoglobulin G and transferrin glycosylation
It is often difficult to be certain which genes underlie the effects seen in association studies. However, variants that disrupt the protein, such as predicted loss of function (pLoF) and missense variants, provide a shortcut to identify genes with a clear biological link to the phenotype of interest. Glycosylation is one of the most common post-translationalmodifications of proteins, and an important biomarker of both disease and its progression. Here, we utilised the power of genetic isolates, gene-based aggregation tests and intermediate phenotypes to assess the effect of rare (MAF−8 ) and for IgG glycan traits at 4 genes (p−7 ). Associations in three of these genes ( FUT8, MGAT3 and RFXAP ) are driven by multiple rare variants simultaneously contributing to protein glycosylation. Association at ST6GAL1 , with a 300-fold up-drifted variant in the Orkney Islands, was detectable by a single-point exome-wide association analysis. Glycome-associated aggregate associations are located in genes already known to have a biological link to protein glycosylation ( FUT6, FUT8 for transferrin; FUT8, MGAT3 and ST6GAL1 for IgG) but also in genes which have not been previously reported (e.g. RFXAP for IgG). To assess the potential impact of rare variants associated with glycosylation on other traits, we queried public repositories of gene-based tests, discovering a potential connection between transferrin glycosylation, MSR1 , galectin-3, insulin-like growth factor 1 and diabetes. However, the exact mechanism behind these connections requires further elucidation.
- Open Access
Genome-wide association study reveals loci with sex-specific effects on plasma bile acids
Bile acids are essential for food digestion and nutrient absorption, but also act as signalling molecules involved in hepatobiliary diseases, gastrointestinal disorders and carcinogenesis. While many studies have focused on the genetic determinants of blood metabolites, research focusing specifically on genetic regulation of bile acids in the general population is currently lacking. Here we investigate the genetic architecture of primary and secondary bile acids in blood plasma, reporting associations with both common and rare variants. By performing genome-wide association analysis (GWAS) of plasma blood levels of 18 bile acids (N = 4923) we identify two significantly associated loci, a common variant mapping to SLCO1B1 (encoding a liver bilirubin and drug transporter) and a rare variant in PRKG1 (encoding soluble cyclic GMP-dependent protein kinase). For these loci, in the sex-stratified GWAS (N♂ = 820, N♀ = 1088), we observe sex-specific effects ( SLCO1B1 β ♂ = -0.51, P = 2.30×10 −13 , β♀ = -0.3, P = 9.90×10 −07 ; PRKG1 β ♂ = -0.18, P = 1.80×10 −01 , β ♀ = -0.79, P = 8.30×10 −11 ), corroborating the contribution of sex to bile acid variability. Using gene-based aggregate tests and whole exome sequencing, we identify rare pLoF and missense variants potentially associated with bile acid levels in 3 genes ( OR1G1, SART1 and SORCS2 ), some of which have been linked with liver diseases.
Open AccessGenome-wide association study reveals loci with sex-specific effects on plasma bile acids
Bile acids are essential for food digestion and nutrient absorption, but also act as signalling molecules involved in hepatobiliary diseases, gastrointestinal disorders and carcinogenesis. While many studies have focused on the genetic determinants of blood metabolites, research focusing specifically on genetic regulation of bile acids in the general population is currently lacking. Here we investigate the genetic architecture of primary and secondary bile acids in blood plasma, reporting associations with both common and rare variants. By performing genome-wide association analysis (GWAS) of plasma blood levels of 18 bile acids (N = 4923) we identify two significantly associated loci, a common variant mapping to SLCO1B1 (encoding a liver bilirubin and drug transporter) and a rare variant in PRKG1 (encoding soluble cyclic GMP-dependent protein kinase). For these loci, in the sex-stratified GWAS (N♂ = 820, N♀ = 1088), we observe sex-specific effects ( SLCO1B1 β ♂ = -0.51, P = 2.30×10 −13 , β♀ = -0.3, P = 9.90×10 −07 ; PRKG1 β ♂ = -0.18, P = 1.80×10 −01 , β ♀ = -0.79, P = 8.30×10 −11 ), corroborating the contribution of sex to bile acid variability. Using gene-based aggregate tests and whole exome sequencing, we identify rare pLoF and missense variants potentially associated with bile acid levels in 3 genes ( OR1G1, SART1 and SORCS2 ), some of which have been linked with liver diseases.
- Open Access
- 24 March 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-13
Genetic regulation of post-translational modification of two distinct proteins
Post-translational modifications diversify protein functions and dynamically coordinate their signalling networks, influencing most aspects of cell physiology. Nevertheless, their genetic regulation or influence on complex traits is not fully understood. Here, we compare the genetic regulation of the same PTM of two proteins – glycosylation of transferrin and immunoglobulin G (IgG). By performing genome-wide association analysis of transferrin glycosylation, we identify 10 significantly associated loci, 9 of which were not reported previously. Comparing these with IgG glycosylation-associated genes, we note protein-specific associations with genes encoding glycosylation enzymes (transferrin - MGAT5, ST3GAL4, B3GAT1; IgG - MGAT3, ST6GAL1), as well as shared associations (FUT6, FUT8). Colocalisation analyses of the latter suggest that different causal variants in the FUT genes regulate fucosylation of the two proteins. Glycosylation of these proteins is thus genetically regulated by both shared and protein-specific mechanisms.
- 24 March 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-13
Open AccessGenetic regulation of post-translational modification of two distinct proteins
Post-translational modifications diversify protein functions and dynamically coordinate their signalling networks, influencing most aspects of cell physiology. Nevertheless, their genetic regulation or influence on complex traits is not fully understood. Here, we compare the genetic regulation of the same PTM of two proteins – glycosylation of transferrin and immunoglobulin G (IgG). By performing genome-wide association analysis of transferrin glycosylation, we identify 10 significantly associated loci, 9 of which were not reported previously. Comparing these with IgG glycosylation-associated genes, we note protein-specific associations with genes encoding glycosylation enzymes (transferrin - MGAT5, ST3GAL4, B3GAT1; IgG - MGAT3, ST6GAL1), as well as shared associations (FUT6, FUT8). Colocalisation analyses of the latter suggest that different causal variants in the FUT genes regulate fucosylation of the two proteins. Glycosylation of these proteins is thus genetically regulated by both shared and protein-specific mechanisms.
- Open Access
Same role but different actors: genetic regulation of post-translational modification of two distinct proteins
Post-translational modifications (PTMs) diversify protein functions and dynamically coordinate their signalling networks, influencing most aspects of cell physiology. Nevertheless, their genetic regulation or influence on complex traits is not fully understood. Here, we compare for the first time the genetic regulation of the same PTM of two proteins – glycosylation of transferrin and immunoglobulin G (IgG). By performing genome-wide association analysis of transferrin glycosylation, we identified 10 significantly associated loci, all novel. Comparing these with IgG glycosylation-associated genes, we note protein-specific associations with genes encoding glycosylation enzymes (transferrin - MGAT5, ST3GAL4, B3GAT1 ; IgG - MGAT3, ST6GAL1 ) as well as shared associations ( FUT6, FUT8 ). Colocalisation analyses of the latter suggest that different causal variants in the FUT genes regulate fucosylation of the two proteins. We propose that they affect the binding of different transcription factors in different tissues, with fucosylation of IgG being regulated by IKZF1 in B-cells and of transferrin by HNF1A in liver.
Open AccessSame role but different actors: genetic regulation of post-translational modification of two distinct proteins
Post-translational modifications (PTMs) diversify protein functions and dynamically coordinate their signalling networks, influencing most aspects of cell physiology. Nevertheless, their genetic regulation or influence on complex traits is not fully understood. Here, we compare for the first time the genetic regulation of the same PTM of two proteins – glycosylation of transferrin and immunoglobulin G (IgG). By performing genome-wide association analysis of transferrin glycosylation, we identified 10 significantly associated loci, all novel. Comparing these with IgG glycosylation-associated genes, we note protein-specific associations with genes encoding glycosylation enzymes (transferrin - MGAT5, ST3GAL4, B3GAT1 ; IgG - MGAT3, ST6GAL1 ) as well as shared associations ( FUT6, FUT8 ). Colocalisation analyses of the latter suggest that different causal variants in the FUT genes regulate fucosylation of the two proteins. We propose that they affect the binding of different transcription factors in different tissues, with fucosylation of IgG being regulated by IKZF1 in B-cells and of transferrin by HNF1A in liver.